Skip to main content

Actemra 400 mg/20 mL injection Images

Generic Name: tocilizumab

This medication has been identified as Actemra 400 mg/20 mL injection. It is supplied by Genentech, Inc.

Actemra is used in the treatment of Giant Cell Arteritis; COVID-19; Cytokine Release Syndrome; Juvenile Idiopathic Arthritis; Polyarticular Juvenile Idiopathic Arthritis and belongs to the drug class interleukin inhibitors. Risk cannot be ruled out during pregnancy. Actemra 400 mg/20 mL injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Actemra 400 mg/20 mL injection medicine

Actemra

Generic Name
tocilizumab
Strength
400 mg/20 mL injection
Availability
Prescription only
Drug Class
Interleukin inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Genentech, Inc.
National Drug Code (NDC)
50242-0137

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.